According to a real-world study, cenobamate was effective in patients with drug-resistant epilepsy (DRE), with 49.3% of patients achieved a 50% or greater reduction in seizure frequency at 3 months.
ATLANTA — Epilepsy experts are getting a better picture of the long-term safety and efficacy of azetukalner, a novel and potent Kv7 potassium channel opener, in patients with treatment-resistant focal ...
About 60-70% of focal epilepsy patients achieve seizure control with first-line antiseizure medications (ASMs). Lamotrigine and levetiracetam demonstrate high efficacy and tolerability for seizure ...
AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...
Epilepsy patients who want to learn how to manage their own unique symptoms can now get individualized information via tablet computer through a research project at the University of Illinois at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback